Updates are available Correction dated 2023-10-09
Click to view Correction: https://doi.org/10.1038/s43018-023-00663-3
-
Authors
Miyazaki, Isao http://orcid.org/0009-0008-3742-1243
Odintsov, Igor
Ishida, Keiji
Lui, Allan J. W. http://orcid.org/0000-0001-7624-3437
Kato, Masanori http://orcid.org/0009-0002-4918-8959
Suzuki, Tatsuya
Zhang, Tom
Wakayama, Kentaro
Kurth, Renate I.
Cheng, Ryan
Fujita, Hidenori
Delasos, Lukas
Vojnic, Morana
Khodos, Inna
Yamada, Yukari
Ishizawa, Kota
Mattar, Marissa S.
Funabashi, Kaoru
Chang, Qing
Ohkubo, Shuichi
Yano, Wakako
Terada, Ryuichiro
Giuliano, Claudio http://orcid.org/0000-0003-1600-544X
Lu, Yue Christine
Bonifacio, Annalisa
Kunte, Siddharth
Davare, Monika A. http://orcid.org/0000-0003-1802-7597
Cheng, Emily H. http://orcid.org/0000-0002-3595-2648
de Stanchina, Elisa
Lovati, Emanuela
Iwasawa, Yoshikazu
Ladanyi, Marc
Somwar, Romel http://orcid.org/0000-0002-5282-6889
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748, 5R25CA020449, U54 D020355, U54 D020355)
Helsinn Healthcare, SA
- License Information
-
More Information
Article History
Received: 10 June 2022
Accepted: 8 August 2023
First Online: 21 September 2023
Change Date: 9 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s43018-023-00663-3
Competing interests
: I.O., A.J.W.L., L.D., I.K., M.S.M., K. Ishizawa, M.V., Y.C.L., R.C., T.Z., R.I.K., S.K., Q.C., E.C., E.d.S. and M.A.D. report no potential conflict of interest. M.L. has received advisory board compensation from Merck, Bristol Myers Squibb, Takeda, Bayer, Lilly Oncology, Janssen and Paige.AI. In addition, research grants unrelated to the current study were obtained from Merus, Loxo Oncology and Elevation Oncology. Research funding from Helsinn Healthcare partially supported this study. R.S. has received research support from Merus, Loxo Oncology and Elevation Oncology, unrelated to the current study. I.M., K. Ishida, M.K., T.S., K.W., H.F., Y.Y., K.F., S.O., W.Y., R.T. and Y.I. are employees of Taiho Pharmaceutical. E.L., C.G. and A.B. are employees of Helsinn Healthcare.
